SG Americas Securities LLC Takes $525,000 Position in STERIS plc (NYSE:STE)

SG Americas Securities LLC purchased a new stake in shares of STERIS plc (NYSE:STEGet Rating) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 2,170 shares of the medical equipment provider’s stock, valued at approximately $525,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Riverview Trust Co acquired a new position in shares of STERIS during the 1st quarter valued at about $29,000. Quent Capital LLC acquired a new position in STERIS in the fourth quarter valued at about $72,000. Aquire Wealth Advisors LLC acquired a new position in STERIS in the fourth quarter valued at about $93,000. UMB Bank N A MO acquired a new position in STERIS in the fourth quarter valued at about $125,000. Finally, AdvisorNet Financial Inc lifted its position in STERIS by 84.8% in the first quarter. AdvisorNet Financial Inc now owns 571 shares of the medical equipment provider’s stock valued at $138,000 after buying an additional 262 shares during the last quarter. Institutional investors and hedge funds own 90.88% of the company’s stock.

Insider Buying and Selling

In other STERIS news, VP John Adam Zangerle sold 2,659 shares of the firm’s stock in a transaction that occurred on Wednesday, June 15th. The shares were sold at an average price of $205.31, for a total transaction of $545,919.29. Following the sale, the vice president now owns 27,936 shares of the company’s stock, valued at $5,735,540.16. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.14% of the company’s stock.

STERIS Stock Up 2.5 %

Shares of NYSE:STE opened at $207.99 on Friday. The firm’s 50-day moving average is $213.07 and its two-hundred day moving average is $225.30. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.04 and a quick ratio of 1.41. STERIS plc has a 1 year low of $192.40 and a 1 year high of $255.93. The firm has a market capitalization of $20.82 billion, a PE ratio of 55.76 and a beta of 0.71.

STERIS (NYSE:STEGet Rating) last released its earnings results on Wednesday, May 11th. The medical equipment provider reported $2.04 earnings per share for the quarter, topping analysts’ consensus estimates of $2.00 by $0.04. STERIS had a net margin of 7.90% and a return on equity of 12.33%. The firm had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.18 billion. Analysts predict that STERIS plc will post 8.71 EPS for the current year.

STERIS Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 23rd. Investors of record on Wednesday, September 7th will be paid a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.90%. This is a positive change from STERIS’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, September 6th. STERIS’s dividend payout ratio is presently 46.11%.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. StockNews.com cut shares of STERIS from a “buy” rating to a “hold” rating in a research report on Wednesday. KeyCorp decreased their target price on shares of STERIS from $256.00 to $240.00 and set an “overweight” rating on the stock in a research report on Thursday. Piper Sandler assumed coverage on shares of STERIS in a research report on Thursday, July 14th. They issued an “overweight” rating and a $240.00 target price on the stock. TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a research report on Tuesday. Finally, JMP Securities cut their price target on shares of STERIS from $270.00 to $250.00 in a research note on Thursday. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $251.71.

About STERIS

(Get Rating)

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Stories

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEGet Rating).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Want More Great Investing Ideas?

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.